Alere

Alere Inc., formerly known as Inverness Medical Innovations, is a provider of diagnostic and health management solutions, focusing on infectious disease, cardiology, oncology, drugs of abuse, and women's health. The company offers a diverse array of products, ranging from over-the-counter tests to laboratory-based diagnostics and integrated home monitoring solutions. Notable brands include Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, BinaxNOW, Cholestech LDX, Clearview iFOB Complete, Determine HBsAg, DoubleCheckGold, and ImmunoComb. Alere operates globally, with a presence in North America, Europe, the Middle East, Asia Pacific, Latin America, and Africa. Its medical diagnostic products facilitate the detection of diseases and enable effective management of patients’ health conditions across various care settings, from hospitals to home environments.

Cindy Horton

Vice President, GM Alere Toxiology Core

10 past transactions

Epocal

Acquisition in 2013
Epocal develops and provides a point of care blood diagnostic systems for healthcare enterprises. The company has produced epoc, a wireless bedside blood testing solution that provides lab results directly to a hand-held mobile computer. Epocal offers its products for hospitals, physicians’ offices, and patients’ homes. The company was founded in 2001 and is based in Ottawa, Canada.

eScreen

Acquisition in 2012
eScreen, Inc. specializes in developing, manufacturing, and marketing employment screening products, primarily focused on drug testing solutions. The company provides a range of innovative products and software designed to streamline and automate the hiring process for employers, donors, and clinics. Notable offerings include the eScreen device, which is an instrumented point-of-collection testing system, and eScreen123, a software solution tailored for occupational health providers. The company also features MyeScreen.com, an online platform for program management and result reporting, as well as MRO Software for verification management. Additional products include the eScreen eCup, a self-contained testing device, the eScreen eReader for digital collections, and mCup and mCheck, which are manual drug testing devices. eScreen also provides web-based services that deliver real-time drug test data, enhancing the efficiency of the screening process. Founded in 1998, eScreen is headquartered in Overland Park, Kansas.

RMD Networks

Acquisition in 2010
RMD Networks specializes in appointment scheduling services that facilitate interactions between doctors and patients. The company's platform allows users to schedule appointments, request medication refills, manage referrals, and create and maintain personal health records. Additionally, it offers tools for addressing insurance and billing concerns, as well as fostering communication between patients and healthcare providers. By streamlining these processes, RMD Networks enhances the overall healthcare experience for both patients and practitioners.

Free & Clear

Acquisition in 2009
Free & Clear, Inc. specializes in providing phone-based tobacco treatment services aimed at employers, health plans, and government agencies. The company offers a comprehensive tobacco cessation program, including Quit For Life, which assists employees and members in quitting smoking and using smokeless tobacco. Additionally, Free & Clear addresses broader health risks linked to chronic diseases through its Mind & Body Program, which focuses on behavior change and encourages individuals to maintain a healthy weight. By delivering these clinically proven interventions, Free & Clear aims to support a healthier workforce and reduce tobacco-related health issues.

Quality Assured Services

Acquisition in 2007
Quality Assured Services is a privately held provider of diagnostic home tests and services.

Cholestech

Acquisition in 2007
Cholestech specializes in point-of-care diagnostics solutions focused on chronic diseases. Founded in 1988 and headquartered in San Diego, California, the company is well-known for its flagship product, the Cholestech LDX system, which measures cholesterol, glucose, liver enzymes, and C-reactive protein to help identify patients at high risk for heart disease. Additionally, Cholestech offers the GDX system for A1C testing. In 2007, the company was acquired by Alere for $326.3 million, further solidifying its presence in the healthcare market.

CLONDIAG chip technologies

Acquisition in 2006
CLONDIAG chip technologies is a company which has developed a multiplexing technology for nucleic acid and immunoassay based diagnostics.

Ischemia Technologies

Acquisition in 2005
Ischemia Technologies is a Denver-based provider of diagnostic tests for cardiovascular and acute care medicines.

Unipath

Acquisition in 2001
Unipath is a manufacturer of women's health, nutritional and clinical diagnostic products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.